HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.

MLA

Ando, Satomi, et al. “HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.” Journal of Immunology (Baltimore, Md. : 1950), vol. 198, no. 3, Feb. 2017, pp. 1210–19. EBSCOhost, https://doi.org/10.4049/jimmunol.1601557.

APA

Ando, S., Hasegawa, A., Murakami, Y., Zeng, N., Takatsuka, N., Maeda, Y., Masuda, T., Suehiro, Y., & Kannagi, M. (2017). HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax. Journal of Immunology (Baltimore, Md. : 1950), 198(3), 1210–1219. https://doi.org/10.4049/jimmunol.1601557

Chicago

Ando, Satomi, Atsuhiko Hasegawa, Yuji Murakami, Na Zeng, Natsuko Takatsuka, Yasuhiro Maeda, Takao Masuda, Youko Suehiro, and Mari Kannagi. 2017. “HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.” Journal of Immunology (Baltimore, Md. : 1950) 198 (3): 1210–19. doi:10.4049/jimmunol.1601557.